Allergan (Ireland) and Cynosure are leading players in Medical Aesthetics Market
According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.
Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=885
The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6% during the forecast period. The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced and user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of the medical aesthetics market during the forecast period.
Allergan (Ireland) held the leading position in the global facial aesthetics products market in 2017. The company has a broad product portfolio and focuses on continuous innovation and development of new products to sustain its market leadership. Over the past few years, the company enhanced its share in the market by introducing new products and securing approvals for various medical aesthetic products. For example, in the past three years, the company received FDA approvals for the Coolsculpting treatment, BOTOX Cosmetic (OnabotulinumtoxinA), JUVÉDERM VOLLURE XC gel filler, and NATRELLE INSPIRA. During the same period, the company also launched new products, including JUVÉDERM VOLBELLA XC and Juvéderm Volite. The company also focuses on inorganic growth strategies such as acquisitions to ensure its growth in the market. For example, in 2017, Allergan acquired ZELTIQ Aesthetics to expand its portfolio of body contouring products. This helped the company to strengthen its position in the medical aesthetics market.
Browse and in-depth TOC on “Medical Aesthetics Market”
170 - Tables
37 - Figures
225 - Pages
Get TOC Details @ https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html

Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestlé S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma PLC (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US) are some of the key players operating in the global medical aesthetics market.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=885
Comments
Post a Comment